ADVERSE REACTIONS
An increased risk of the following serious adverse reactions has been associated with the use of oral contraceptives (see WARNINGS):
-
Thrombophlebitis and thrombosis
-
Arterial thromboembolism
-
Pulmonary embolism
-
Myocardial infarction and coronary thrombosis
-
Cerebral hemorrhage
-
Cerebral thrombosis
-
Hypertension
-
Gallbladder disease
-
Benign and malignant liver tumors, and other hepatic lesions
There is evidence of an association between the following conditions and the use of oral contraceptives, although additional confirmatory studies are needed:
The following adverse reactions have been reported in patients receiving oral contraceptives and are believed to be drug-related:
-
Nausea
-
Vomiting
-
Gastrointestinal symptoms (such as abdominal cramps and bloating)
-
Breakthrough bleeding
-
Spotting
-
Change in menstrual flow
-
Amenorrhea during or after use
-
Temporary infertility after discontinuation of use
-
Edema
-
Chloasma or melasma, which may persist
-
Breast changes: tenderness, enlargement, secretion
-
Change in weight (increase or decrease)
-
Change in cervical erosion or secretion
-
Diminution in lactation when given immediately postpartum
-
Cholestatic jaundice
-
Migraine
-
Rash (allergic)
-
Mental depression
-
Reduced tolerance to carbohydrates
-
Vaginal candidiasis
-
Change in corneal curvature (steepening)
-
Intolerance to contact lenses
The following adverse reactions or conditions have been reported in users of oral contraceptives and the association has been neither confirmed nor refuted:
|